ストックスクリーナーアプリを入手
6.77
3.56%
-0.25
アフターアワーズ：
6.77
前日終値:
$7.02
開ける：
$7.06
24時間の取引高:
43,880
Relative Volume:
0.50
時価総額：
$188.73M
収益：
$21.25M
当期純損益:
$-16.05M
株価収益率:
-11.10
EPS:
-0.61
ネットキャッシュフロー:
$-17.14M
1週間 パフォーマンス:
+0.30%
1か月 パフォーマンス:
+4.15%
6か月 パフォーマンス:
+20.68%
1年 パフォーマンス:
-31.06%
1日の値動き範囲:
$6.70
$7.06
1週間の範囲:
$6.53
$7.06
52週間の値動き範囲:
$3.96
$11.49
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
名前
Fennec Pharmaceuticals Inc
セクター
電話
(919) 636-4530
住所
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
6.77 | 188.73M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-22 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 開始されました | CapitalOne | Overweight |
| 2022-08-08 | 再開されました | Craig Hallum | Buy |
| 2020-06-05 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 開始されました | Goldman | Buy |
Fennec Pharmaceuticals Inc (FENC) 最新ニュース
(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily
Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily
Trading (FENC) With Integrated Risk Controls - Stock Traders Daily
Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals director sells shares worth $8,088 By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals director sells shares worth $8,088 - Investing.com India
(FENC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 10,000 Shares of Stock - MarketBeat
Rostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
Fennec Pharmaceuticals Inc. - MENAFN.COM
Norgine introduces PEDMARQSI in Germany for pediatric cancer care - MSN
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals director Raykov sells $66,600 in shares - MSN
Fennec Pharmaceuticals Announces Commercial Launch of Pedmarqsi in Germany - Marketscreener.com
Fennec Pharmaceuticals' Pedmarqsi Launched in Germany by Norgine Pharmaceuticals - Marketscreener.com
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - The Manila Times
Fennec Pharmaceuticals Brief: Announcing Commercial Launch of PEDMARQSI In Germany - Marketscreener.com
Insider Sell Alert: Rosty Raykov Sells 10,000 Shares of Fennec P - GuruFocus.com
Fennec Pharmaceuticals director Raykov sells $66,600 in shares By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50-Day Moving AverageHere's What Happened - MarketBeat
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Short Interest Update - MarketBeat
Trend Tracker for (FENC) - Stock Traders Daily
Fennec PharmaA Sound Investment? - RTTNews
Fennec Pharmaceuticals (NASDAQ:FENC) shareholder returns have been respectable, earning 41% in 3 years - Simply Wall St
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Barclays PLC Raises Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Large Decrease in Short Interest - MarketBeat
Learn to Evaluate (FENC) using the Charts - Stock Traders Daily
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in Stock - MarketBeat
Barclays PLC Grows Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares By Investing.com - Investing.com Australia
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares - Investing.com
Franklin Resources Inc. Has $74,000 Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
State Street Corp Has $1.64 Million Stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc (FENC) 財務データ
収益
当期純利益
現金流量
EPS
Fennec Pharmaceuticals Inc (FENC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A | Director |
Feb 14 '25 |
Sale |
6.82 |
1,186 |
8,089 |
53,020 |
6.45%
1.23%
大文字化:
|
ボリューム (24 時間):